IA
BSTG

IFP Advisors’s Biostage, Inc. Common Stock BSTG Stock Holding History

IFP Advisors’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500
Closed -$1K – 4025
2015
Q4 		$1K Buy
+500
New +$697 ﹤0.01% 3643

Other funds holding BSTG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IFP Advisors's BSTG Position: Q1 2016 in Review

IFP Advisors sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2016, closing a stake of 500 shares — an estimated $1K sold.

IFP Advisors first reported a position in BSTG in Q4 2015 and held it in 1 quarter. The position peaked at $1K in Q4 2015. 23 funds tracked by Wall St. Rank hold BSTG as of Q1 2016.

  • IFP Advisors reported no remaining Biostage, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • IFP Advisors sold 500 Biostage, Inc. Common Stock shares in Q1 2016, an estimated $1K.
  • IFP Advisors first reported a position in Biostage, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • IFP Advisors's Biostage, Inc. Common Stock position peaked at $1K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2016.

Based on IFP Advisors's 13F filing for Q1 2016, filed 2 May 2016.